⌘K
Loading ticker…
As of 2026-08-24, PROCEPT BioRobotics Corporation Common Stock (PRCT) has a 3-month relative strength percentile of 16 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 39. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.3%, relative volume 0.45×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
PRCT is held by 24 ETFs as of May 2026. Top owner: BOTZ at 0.30% weight, $11M notional. Top 3 carry $26M.
Held by 51 ETFs · $206M across latest filings · largest weight 1.57% (XHE).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| BOTZGlobal X Robotics & Artificial Intelligence ETF | 0.30% | $11M | −0.11 pp |
| VTWO | 0.04% | $7M | — |
| SCHASchwab U.S. Small-Cap ETF | 0.03% | $7M | — |
| VHTVanguard Health Care ETF | 0.02% | $4M | — |
| VTWG | 0.08% |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| $1M |
| — |
| ESML | 0.04% | $1M | +0.01 pp |
| SCHBSchwab U.S. Broad Market ETF | 0.00% | $917K | — |
| DTEC | 0.90% | $672K | +0.22 pp |
| ONEQ | 0.00% | $542K | — |
| FSCC | 0.18% | $509K | new |
Showing 10 of 24 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PRCT Jan avg: -3.45% median: -7.16% win: 25% σ: 9.40% n: 4 2022-04-12 → 2026-07-31 | PRCT Feb avg: -8.05% median: -7.48% win: 25% σ: 11.09% n: 4 2022-04-12 → 2026-07-31 | PRCT Mar avg: -5.29% median: -3.61% win: 50% σ: 14.95% n: 4 2022-04-12 → 2026-07-31 | PRCT Apr avg: 1.43% median: 4.16% win: 60% σ: 6.65% n: 5 2022-04-12 → 2026-07-31 | PRCT May avg: 12.48% median: 10.01% win: 100% σ: 7.27% n: 5 2022-04-12 → 2026-07-31 | PRCT Jun avg: -6.74% median: -8.00% win: 20% σ: 9.26% n: 5 2022-04-12 → 2026-07-31 | PRCT Jul avg: -3.02% median: -2.57% win: 40% σ: 14.37% n: 5 2022-04-12 → 2026-07-31 | PRCT Aug avg: 3.08% median: 2.37% win: 50% σ: 17.36% n: 4 2022-04-12 → 2026-07-31 (current) | PRCT Sep avg: -2.78% median: -1.20% win: 50% σ: 6.21% n: 4 2022-04-12 → 2026-07-31 | PRCT Oct avg: -0.27% median: 2.46% win: 50% σ: 14.16% n: 4 2022-04-12 → 2026-07-31 | PRCT Nov avg: 8.03% median: 0.32% win: 50% σ: 21.07% n: 4 2022-04-12 → 2026-07-31 | PRCT Dec avg: -1.64% median: -1.93% win: 25% σ: 11.81% n: 4 2022-04-12 → 2026-07-31 |